Rosemary Crane

Rosemary Crane

Director/Board Member at CERTARA, INC.

Net worth: 2 M $ as of 2024-03-30

64 year
Health Technology
Consumer Services
Finance

Profile

Rosemary A.
Crane
currently works at Teva Pharmaceutical Industries Ltd., as Independent Director from 2015, HMH Hospitals Corp, Inc., as Director-Discovery & Innovation, Catalent Pharma Solutions, Inc., as Director from 2018, Tarsus Pharmaceuticals, Inc., as Independent Director from 2021, Certara, Inc., as Independent Director from 2022, Hackensack Meridian Health Center For Discovery & Innovation, as Director, and The State University of New York, as Member-Foundation Board.
Ms. Crane also formerly worked at Epocrates LLC, as President, Chief Executive Officer & Director in 2011, STRATA Skin Sciences, Inc., as President, Chief Executive Officer & Director in 2014, Epocrates, Inc. (Research), as President & Chief Executive Officer in 2011, MELA Sciences Inc., as President & Chief Executive Officer from 2013 to 2014, Johnson & Johnson, as Group Chairman-OTC & Nutritional Group from 2006 to 2008, Zealand Pharma A, as Vice Chairman from 2015 to 2019, Cipher Pharmaceuticals, Inc., as Director in 2016, Targanta Therapeutics Corp., as Director from 2008 to 2009, Edge Therapeutics, Inc., as Independent Director from 2017 to 2019, Unilife Corp., as Independent Director from 2016 to 2017, Unilife Medical Solutions, Inc., as Director, Catalent, Inc., as Independent Director from 2018 to 2024, Bristol Myers Squibb Co., as President-US Primary Care Division from 2000 to 2002, and Apple Tree venture Managemnet Llc, as Partner in 2013.
Ms. Crane received her undergraduate degree in 1981 from State University of New York College at Oswego and Masters Business Admin degree in 1986 from Kent State University (Ohio).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-08-03 82,507 ( 0.01% ) 1 M $ 2024-03-30
2023-12-03 16,880 ( 0.01% ) 952 876 $ 2024-03-30
2023-05-22 9,324 ( 0.01% ) 166 713 $ 2024-03-30
2023-06-21 2,000 ( 0.01% ) 72 700 $ 2024-03-30

Rosemary Crane active positions

CompaniesPositionStart
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Director/Board Member 2015-08-31
TARSUS PHARMACEUTICALS, INC. Director/Board Member 2021-08-10
CERTARA, INC. Director/Board Member 2022-07-20
The State University of New York Corporate Officer/Principal -
Hackensack Meridian Health Center For Discovery & Innovation Director/Board Member -
Director/Board Member 2018-02-28
Corporate Officer/Principal -
All active positions of Rosemary Crane

Former positions of Rosemary Crane

CompaniesPositionEnd
CATALENT, INC. Director/Board Member 2024-01-24
ZEALAND PHARMA A/S Director/Board Member 2019-04-03
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Rosemary Crane's experience

Training of Rosemary Crane

State University of New York College at Oswego Undergraduate Degree
Kent State University (Ohio) Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rosemary Crane's experience

Connections

99

1st degree connections

23

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies9
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

JOHNSON & JOHNSON

Health Technology

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

CIPHER PHARMACEUTICALS INC.

Health Technology

STRATA SKIN SCIENCES, INC.

Health Technology

ZEALAND PHARMA A/S

Health Technology

CATALENT, INC.

Health Technology

TARSUS PHARMACEUTICALS, INC.

Health Technology

CERTARA, INC.

Technology Services

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Electronic Technology

Finance

Health Technology

Finance

Hackensack Meridian Health Center For Discovery & Innovation

MELA Sciences Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Rosemary Crane